A Phase III randomised, controlled trial of exercise during chemotherapy for patients commencing first-line treatment for ovarian cancer.

See ANZCTR for full trial details >

 

Trial Summary:

The aim of this study is to determine effect of a structured exercise intervention on physical wellbeing at post-intervention and 6 and 12 months post-randomisation.

Supported By:

This study is a collaboration between Queensland University of Technology (QUT), the Australia New Zealand Gynaecological Oncology Group (ANZGOG) and the NHMRC Clinical Trials Centre (CTC), University of Sydney

Eligibility:

Women aged ≥18 years, newly diagnosed with epithelial ovarian, primary peritoneal or fallopian tube cancer. Key eligibility include  sufficient fluency in English to comprehend data collection and intervention requirements and scheduled for chemotherapy.

Registration ID:

ACTRN12614001311640

Participation:

Australia

Australian Lead Group:

ANZGOG

Status:

Recruiting

Activation Date:

2014

Chairs:

A/Prof Sandi Hayes

Contact:

echo.study@sydney.edu.au